Amarin Pharma Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Oct 6, 2020
  • No warning letters matched by name
Inspections 4 0 OAI
Recalls 0 0 Class I
Warning letters 0 None on file
510(k) clearances 0 None on file

Amarin Pharma Inc. has 0 FDA recalls, 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Amarin Pharma Inc." is on file.

What these totals cover: FDA records filed under the name "Amarin Pharma Inc." and its spelling variant "Amarin Pharma".

Latest inspection
Oct 6, 2020 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections4Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Amarin Pharma Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Amarin Pharma Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300000
202200000
202100000
202010000
201910000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Amarin Pharma Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Amarin Pharma Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

4 inspections from Oct 29, 2013 to Oct 6, 2020.

DateSiteProductClassificationFEI
Oct 6, 2020Bridgewater, NJDrugsNo Action Indicated (NAI)3015820997
Aug 2, 2019Bedminster, NJDrugsNo Action Indicated (NAI)3010326898
Sep 9, 2014Bedminster, NJDrugsVoluntary Action Indicated (VAI)3010326898
Oct 29, 2013Bedminster, NJDrugsNo Action Indicated (NAI)3010326898
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3015820997Bridgewater, NJ1Oct 6, 2020
FEI 3010326898Bedminster, NJ3Aug 2, 2019

Amarin Pharma Inc. and the FDA: common questions

Has Amarin Pharma Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Amarin Pharma Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Amarin Pharma Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Amarin Pharma Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Amarin Pharma Inc.?

The most recent FDA inspection on file ended Oct 6, 2020 at Bridgewater, NJ and was classified NAI. FDA has 4 inspections of Amarin Pharma Inc. on file.

Need more than this page shows? Ask about Amarin Pharma Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.